Orbimed Advisors - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2019$8,468,000
+6.7%
786,600
+26.0%
0.16%
+30.9%
Q2 2019$7,934,000
-89.1%
624,249
-66.8%
0.12%
-89.1%
Q1 2019$72,925,000
+37.9%
1,880,000
-27.7%
1.13%
+15.4%
Q4 2018$52,887,000
-57.4%
2,598,883
-3.9%
0.98%
-34.5%
Q3 2018$124,033,000
-23.3%
2,705,181
-1.0%
1.49%
-22.5%
Q2 2018$161,650,000
-10.1%
2,732,881
+3.5%
1.93%
-13.5%
Q1 2018$179,765,000
-16.8%
2,641,661
+20.9%
2.23%
-18.4%
Q4 2017$215,941,000
-25.7%
2,184,535
-9.9%
2.73%
-1.6%
Q3 2017$290,482,000
+37.0%
2,425,7350.0%2.78%
+24.9%
Q2 2017$212,009,000
+153.8%
2,425,735
+8.0%
2.22%
+134.6%
Q1 2017$83,548,000
+19.6%
2,245,925
-1.3%
0.95%
+6.4%
Q4 2016$69,868,000
-56.3%
2,275,825
-4.5%
0.89%
-51.1%
Q3 2016$159,815,000
+81.0%
2,383,525
-19.6%
1.82%
+97.6%
Q2 2016$88,298,000
+9.2%
2,964,025
+7.6%
0.92%
+8.2%
Q1 2016$80,868,000
-53.9%
2,753,425
+23.0%
0.85%
-46.4%
Q4 2015$175,524,000
+94.8%
2,238,825
+87.3%
1.59%
+74.8%
Q3 2015$90,093,000
-18.0%
1,195,500
+27.1%
0.91%
+12.8%
Q2 2015$109,838,000
+10.7%
940,800
+123.9%
0.81%
-4.8%
Q1 2015$99,214,000
+108.9%
420,200
+67.5%
0.85%
+86.6%
Q4 2014$47,488,000
-27.1%
250,900
-8.1%
0.45%
-33.3%
Q3 2014$65,106,000
+225.4%
272,900
-10.0%
0.68%
+189.8%
Q2 2014$20,005,000
+52.8%
303,100
+2.7%
0.24%
-15.2%
Q2 2013$13,089,000295,0000.28%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders